过去一年中添加的文章,按日期排序

UsIL-6: An unbalanced learning strategy for identifying IL-6 inducing peptides by undersampling technique

Y Liao, S Chen, Y Bin, J Zhao, X Feng… - Computer Methods and …, 2024 - Elsevier
77 天前 - … development of diagnosis and immunotherapy. Although the … time point of severe
COVID-19 cases that culminates in … indexes in the blood of COVID-19 cases, put forward the …

Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis

AA Kulkarni, C Hennessy, G Wilson, V Ramesh… - Clinical lung cancer, 2024 - Elsevier
79 天前 - immunotherapy or targeted therapy did not appear to significantly affect COVID-19
mortality… More research is necessary to elucidate the effects of chemotherapy on COVID-19

Unilateral Cortical Autoimmune Encephalitis: A Case Series and Comparison to Late-onset Rasmussen's Encephalitis (P7-14.013)

S Damman, P Sukpornchairak, A Ahituv, A Chen… - Neurology, 2024 - AAN Enterprises
79 天前 - … inhibitors), and two post-COVID-19. Serologically, ten patients were seronegative,
one … more responsive to immunotherapy. In cases refractory to immunotherapy, interventions …

Corticospinal and Dorsal Column Tractopathy in the Setting of Preceding COVID-19 Infection (P5-13.010)

A Alimohammadi, T Chen, R Herrington - Neurology, 2024 - AAN Enterprises
79 天前 - … poor prognosis despite immunotherapy. Few cases similar to ours have been
described in association with COVID-19 infection, with good outcome with immunotherapy. …

The dawn of a new Era: mRNA vaccines in colorectal cancer immunotherapy

J Song, Y Zhang, C Zhou, J Zhan, X Cheng… - International …, 2024 - Elsevier
80 天前 - … successful application for the prevention of COVID-19. mRNA vaccine technology
won … As a promising new immunotherapy in CRC and other multiple cancer treatments, the …

A unified cross-attention model for predicting antigen binding specificity to both HLA and TCR molecules

C Yu, X Fang, H Liu - arXiv preprint arXiv:2405.06653, 2024 - arxiv.org
81 天前 - … Notably, on a large-scale COVID-19 antigen-TCR binding test set, our method …
confirm that our approach effectively predicts immunotherapy response and clinical outcomes. …

[HTML][HTML] CASE REPORT: Fulminant acute hemorrhagic Leukoencephalitis (AHLE): A rare and ruinous outcome with cerebral herniation (COVID-19)

AS Safan, Z Noorain, MA Atta, R Thekkoth, AM Suliman… - Eneurologicalsci, 2024 - Elsevier
83 天前 - … low as 14% despite immunotherapy and raised intracranial pressure measures [4].
We herein report a rare case of fulminant AHLE-COVID-19 with rapidly progressive global …

Abstract CT030: Randomized placebo-controlled, biomarker-stratified phase 1b microbiome modulation trial for metastatic melanoma demonstrates impact of …

IC Glitza Oliva, YD Seo, CN Spencer, JR Wortman… - Cancer Research, 2024 - AACR
84 天前 - … of inflammation after vanco, which also normalized by first dose of immunotherapy.
… The study was limited by poor accrual during the COVID-19 pandemic. Nonetheless, …

Abstract CT004: A single arm phase 2 study of TVEC in patients with invasive cutaneous SCC: A novel therapeutic approach for low risk tumors

C Curiel-Lewandrowski, DB Stratton, AC Adams, H Cui… - Cancer Research, 2024 - AACR
84 天前 - … A total of 11 subjects were recruited, due to the COVID-19 pandemic and 100% CR
observed in … Further studies evaluating the role of intralesional immunotherapy should be …

[HTML][HTML] Reassessing human MHC-I genetic diversity in T cell studies

RC Slieker, DO Warmerdam, MH Vermeer… - Scientific reports, 2024 - nature.com
85 天前 - … been extensively used in T cell analyses for COVID-19 patients and are currently
used in the development of immunotherapies for cancer. However, the immense diversity of …